Elsevier launches a new corporate website
We are pleased to announce the launch of our new corporate website. We would very much appreciate it if you would take some time to become acquainted with the new architecture, navigation and design, e-mailing your feedback to: NewCWS@elsevier.com.
Amsterdam, 20 January, 2004 - We are pleased to announce the launch of the new Elsevier corporate website Further development of the site will continue through 2004-5.
We are confident that the site′s new interface, content and search functionality provides an enriched user experience. Intuitive navigation and architecture will connect you with the information you need about all our products and services - from one entry point.
Using the FAST technology of Scirus, our free Web search engine, you can search precisely for scientific, medical and technical information:
- within all Elsevier products (indexed search)
- across all Elsevier websites (crawl)
Providing tailored content, the following customer segments have unique entry points on the new website:
- Career seekers
Over the next 6 months, we will continue developing the website, to include additional unique entry points for:
- Students and Faculty
- Business Partners
Further areas for development will include:
- Regional content
- Local-language products
- End-to-end e-commerce
- Personalization features
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence,and ClinicalKey—and publishes over 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.
The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).